Related Experiment Video
Updated: Oct 6, 2025

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
Published on: May 5, 2022
Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV-2
Artem Pliss1, Andrey N Kuzmin1, Paras N Prasad1
1Institute for Lasers, Photonics and Biophotonics and Department of Chemistry, University at Buffalo, The State University of New York, Buffalo, New York 14260, United States.
Abstract:
The SARS-CoV-2 virus is notorious for its neuroinvasive capability, causing multiple neurological conditions. The neuropathology of SARS-CoV-2 is increasingly attributed to mitochondrial dysfunction of brain microglia cells. However, the changes in biochemical content of mitochondria that drive the progression of neuro-COVID remain poorly understood. Here we introduce a Raman microspectrometry approach that enables the molecular profiling of single cellular organelles to characterize the mitochondrial molecular makeup in the infected microglia cells. We found that microglia treated with either spike protein or heat-inactivated SARS-CoV-2 trigger a dramatic reduction in mtDNA content and an increase in phospholipid saturation levels. At the same time, no significant changes were detected in Golgi apparatus and in lipid droplets, the organelles that accommodate biogenesis and storage of lipids. We hypothesize that transformations in mitochondria are caused by increased synthesis of reactive oxygen species in these organelles. Our findings call for the development of mitochondria-targeted therapeutic approaches to limit neuropathology associated with SARS-CoV-2.
Insights
SARS-CoV-2 infection impairs brain microglia mitochondria, reducing mitochondrial DNA and increasing lipid saturation. This suggests new therapeutic targets for neuro-COVID.
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- SARS-CoV-2 exhibits neuroinvasive properties, leading to neurological conditions.
- Mitochondrial dysfunction in brain microglia is a key factor in SARS-CoV-2 neuropathology.
- The specific biochemical changes in mitochondria driving neuro-COVID progression are not well understood.
Purpose of the Study:
- To molecularly profile mitochondria in SARS-CoV-2-infected microglia using Raman microspectrometry.
- To characterize the biochemical alterations within microglia mitochondria during SARS-CoV-2 infection.
- To understand the molecular basis of mitochondrial dysfunction in neuro-COVID.
Main Methods:
- Utilized Raman microspectrometry for molecular profiling of single cellular organelles.
- Analyzed microglia cells treated with SARS-CoV-2 spike protein or heat-inactivated virus.
- Compared molecular changes in mitochondria, Golgi apparatus, and lipid droplets.
Main Results:
- Observed a significant reduction in mitochondrial DNA (mtDNA) content in treated microglia.
- Detected an increase in phospholipid saturation levels within mitochondria.
- Found no significant changes in the Golgi apparatus or lipid droplets.
Conclusions:
- Microglia mitochondrial dysfunction, characterized by mtDNA reduction and altered lipid saturation, is a key feature of SARS-CoV-2 infection.
- Increased reactive oxygen species synthesis is hypothesized to drive these mitochondrial transformations.
- Mitochondria-targeted therapies are proposed as a strategy to mitigate SARS-CoV-2-induced neuropathology.
Related Concept Videos
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Mitochondrial Membranes
ATP Synthase: Mechanism
Mitochondria
Animal Mitochondrial Genetics
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...

